Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.

Saved in:
Bibliographic Details
Title: Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
Authors: Klamroth R; Vivantes Klinikum, Landsberger Allee 49, 10249 Berlin, Germany.; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany., Recht M; Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.; National Bleeding Disorders Foundation, 1230 Avenue of the Americas 16th Floor, New York, NY 10020, USA., Key NS; UNC Blood Research Center and Department of Medicine, University of North Carolina, 8008 Mary Ellen Jones Building, CB7035 Chapel Hill, NC 27514, USA., Miesbach W; Department of Haemostaseology and Haemophilia, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany., Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, 1500 East Medical Drive, Ann Arbor, MI 48109-5718, USA., Kaczmarek R; Department of Pediatrics, Indiana University School of Medicine, 1044 West Walnut Street, R4-116, Indianapolis, IN 46202, USA., Drelich D; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Salazar B; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Le Quellec S; CSL Behring Europe, Philipp-Reis-Strasse 2, 65795 Hattersheim am Main, Germany., Monahan PE; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., Galante N; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA., van der Valk P; Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, University Utrecht, Van Creveldkliniek, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Tarrant J; CSL Behring, 1020 First Avenue, King of Prussia, PA 61501, USA.
Source: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2025 Aug 18; Vol. 33 (3), pp. 101568. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2329-0501
DOI:10.1016/j.omtm.2025.101568